For instance, pharmacological enhancement of KCC2 activity using small molecules like CLP290 reinstates inhibitory neurotransmission, normalizes chloride homeostasis, and reverses cognitive deficits in AD mouse models (Keramidis et al., 2023). This evidence concerns the gene SLC12A5 and Alzheimer disease.